Peptide Vaccines for Infectious Disease

4 articles in this topic.

Complete Guides

Peptide Vaccines for Infectious DiseaseGuide

Peptide-Based COVID Vaccine Candidates

Three peptide COVID vaccines reached clinical trials using T-cell epitopes instead of mRNA. CoVac-1, EpiVacCorona, and UB-612 results.

19 min read|Mar 20, 2026

All Articles

Peptide Vaccines for Infectious Disease

Peptide Vaccines for HPV: Beyond Gardasil

How therapeutic HPV peptide vaccines target E6 and E7 oncoproteins to treat existing infections, what clinical trials show, and where the field stands now.

14 min read|Mar 25, 2026

Peptide Vaccines for Infectious Disease

Peptide Vaccines for HIV: Decades of Failure and New Hope

HIV peptide vaccines have failed for 40 years. Germline-targeting strategies and peptide-liposome platforms now show the first real signals. Here is the full story.

14 min read|Mar 25, 2026

Peptide Vaccines for Infectious Disease

CMV Peptide Vaccines: Protecting Transplant Patients

CMVPepVax and pp65 peptide vaccines aim to prevent CMV reactivation in transplant recipients. Phase I/II trial data, T-cell responses, and the pipeline.

14 min read|Mar 21, 2026